79 related articles for article (PubMed ID: 26905417)
1. Limitations of a Cardiac Risk (QRISK2) Calculator in Patients with High Density Lipoprotein (HDL).
Minhas JS; Patel P; Gupta PK
High Blood Press Cardiovasc Prev; 2016 Mar; 23(1):47-50. PubMed ID: 26905417
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical coronary artery disease in humans with hyperalphalipoproteinemia is associated with distinct differences in the high-density lipoprotein phosphosphingolipidome.
Hancock-Cerutti W; Lhomme M; Dauteuille C; Lecocq S; Chapman MJ; Rader DJ; Kontush A; Cuchel M
J Clin Lipidol; 2017; 11(5):1192-1200.e3. PubMed ID: 28826666
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as Predictors of Cardiovascular Disease in Chinese.
Gu X; Yang X; Li Y; Cao J; Li J; Liu X; Chen J; Shen C; Yu L; Huang J; Gu D
Am J Cardiol; 2015 Oct; 116(7):1063-70. PubMed ID: 26250998
[TBL] [Abstract][Full Text] [Related]
4. The relationship between cardiovascular disease risk prediction scores and vascular function and morphology in rheumatoid arthritis.
Sandoo A; Chanchlani N; Hodson J; Smith JP; Douglas KM; Kitas GD
Clin Exp Rheumatol; 2014; 32(6):914-21. PubMed ID: 25152090
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort.
McGarrah RW; Craig DM; Haynes C; Dowdy ZE; Shah SH; Kraus WE
Atherosclerosis; 2016 Mar; 246():229-35. PubMed ID: 26803432
[TBL] [Abstract][Full Text] [Related]
6. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
[TBL] [Abstract][Full Text] [Related]
7. Improved plasma cholesterol efflux capacity from human macrophages in patients with hyperalphalipoproteinemia.
El Khoury P; Plengpanich W; Frisdal E; Le Goff W; Khovidhunkit W; Guerin M
Atherosclerosis; 2014 May; 234(1):193-9. PubMed ID: 24674903
[TBL] [Abstract][Full Text] [Related]
8. Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events: reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial with previous surrogate endpoint trials.
Michos ED; Sibley CT; Baer JT; Blaha MJ; Blumenthal RS
J Am Coll Cardiol; 2012 Jun; 59(23):2058-64. PubMed ID: 22520249
[TBL] [Abstract][Full Text] [Related]
9. High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
Duprez DA; Otvos J; Tracy RP; Feingold KR; Greenland P; Gross MD; Lima JA; Mackey RH; Neaton JD; Sanchez OA; Jacobs DR
J Am Heart Assoc; 2015 Sep; 4(9):e002295. PubMed ID: 26370448
[TBL] [Abstract][Full Text] [Related]
10. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
[TBL] [Abstract][Full Text] [Related]
11. The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study.
Mortensen MB; Afzal S; Nordestgaard BG; Falk E
Eur Heart J; 2015 Sep; 36(36):2446-53. PubMed ID: 26082084
[TBL] [Abstract][Full Text] [Related]
12. High-density lipoprotein cholesterol: origins and the path ahead.
Oda MN
Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):133-41. PubMed ID: 25692918
[TBL] [Abstract][Full Text] [Related]
13. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
[TBL] [Abstract][Full Text] [Related]
14. [Risk of cardiovascular death in relation to blood lipid composition in male inhabitants of Tyumen: results of a 12-year prospective study].
Akimova EV; Gakova EI; Pushkarev GS; Smaznov VIu; Kaiumova MM; Gafarov VV; Kuznetsov VA
Ter Arkh; 2012; 84(9):41-6. PubMed ID: 23091852
[TBL] [Abstract][Full Text] [Related]
15. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
[TBL] [Abstract][Full Text] [Related]
16. High-density lipoprotein subclass profile and mortality in patients with coronary artery disease: Results from the GENES study.
Elbaz M; Faccini J; Bongard V; Ingueneau C; Taraszkiewicz D; Perret B; Ferrières J; Ruidavets JB; Vindis C
Arch Cardiovasc Dis; 2016 Nov; 109(11):607-617. PubMed ID: 27693051
[TBL] [Abstract][Full Text] [Related]
17. Reassessing lipid metabolism and its potentialities in the prediction of cardiovascular risk.
Silva IT; Almeida-Pititto Bd; Ferreira SR
Arch Endocrinol Metab; 2015 Apr; 59(2):171-80. PubMed ID: 25993681
[TBL] [Abstract][Full Text] [Related]
18. Plasma lipoprotein levels as predictors of cardiovascular death in women.
Bass KM; Newschaffer CJ; Klag MJ; Bush TL
Arch Intern Med; 1993 Oct; 153(19):2209-16. PubMed ID: 8215724
[TBL] [Abstract][Full Text] [Related]
19. Flow-mediated dilation, carotid wall thickness and HDL function in subjects with hyperalphalipoproteinemia.
Vigna GB; Satta E; Bernini F; Boarini S; Bosi C; Giusto L; Pinotti E; Tarugi P; Vanini A; Volpato S; Zimetti F; Zuliani G; Favari E
Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):777-83. PubMed ID: 24680225
[TBL] [Abstract][Full Text] [Related]
20. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
Honda H; Ueda M; Kojima S; Mashiba S; Michihata T; Takahashi K; Shishido K; Akizawa T
Atherosclerosis; 2012 Feb; 220(2):493-501. PubMed ID: 22119537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
